LexDanaLexDanabeta
Inventor

GUILLAUME LEVILAIN

Inventor
DE

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds17%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07HSugars8%
PatentTitleYear
12,060,382Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 b-L-ribofuranosyl)-1H-benzimidazole202411,912,692Substituted S-alaninate derivatives202411,298,367Prodrugs of substituted triazole derivatives and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to BAYER AG (2)· patent assignee history
2022Patents assigned to Bayer Pharma AG (1)· patent assignee history
2022–2024Based in DE· patent location history
2024Patents assigned to TAKEDA PHARMACEUTICALS CO (1)· patent assignee history
2024Based in FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER AG22022–2024
Bayer Pharma AG12022
TAKEDA PHARMACEUTICALS CO12024
Locations
LocationPatentsSpan
DE22022–2024
FR12024